Raphael Pharmaceutical (RAPH) Profit After Tax (2020 - 2024)
Raphael Pharmaceutical (RAPH) reported Profit After Tax of -$395000.0 for Q4 2024, down 423.77% on a YoY basis from $122000.0 in Q1 2024, and down 21.17% sequentially from -$326000.0 in Q3 2024.
Raphael Pharmaceutical (RAPH) Profit After Tax (2020 - 2024) Analysis & Trends
Raphael Pharmaceutical (RAPH) has 5 years of Profit After Tax data on file, last reported at -$395000.0 in Q4 2024.
- For the quarter ending Q4 2024, Profit After Tax fell 423.77% year-over-year to -$395000.0; the trailing twelve-month figure through Dec 2024 stood at -$1.5 million (down 18.3% YoY), and the FY2025 full-year result was -$1.3 million, up 15.8% from the prior year.
- Profit After Tax retreated to -$395000.0 in Q4 2024, from -$326000.0 in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $122000.0 in Q4 2023 to a low of -$1.4 million in Q3 2022.
- A 5-year average of -$471529.4 and a median of -$395000.0 in 2024 frame the typical range for Profit After Tax.
- Across the five-year window, Profit After Tax soared 111.06% in 2023 and slumped 423.77% in 2024, its largest moves.
- Tracing RAPH's Profit After Tax over 5 years: stood at -$230000.0 in 2020, then tumbled by 146.52% to -$567000.0 in 2021, then slumped by 94.53% to -$1.1 million in 2022, then soared by 111.06% to $122000.0 in 2023, then tumbled by 423.77% to -$395000.0 in 2024.
- Business Quant data shows RAPH's Profit After Tax at -$395000.0 in Q4 2024, -$326000.0 in Q3 2024, and -$248000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 369.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.35 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 274.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Raphael Pharmaceutical | 27.37 Mn | 27.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -395,000.00 |
| Sep 30, 2024 | -326,000.00 |
| Jun 30, 2024 | -248,000.00 |
| Mar 31, 2024 | -550,000.00 |
| Dec 31, 2023 | 122,000.00 |
| Sep 30, 2023 | -725,000.00 |
| Jun 30, 2023 | -417,000.00 |
| Mar 31, 2023 | -264,000.00 |
| Dec 31, 2022 | -1.10 Mn |
| Sep 30, 2022 | -1.44 Mn |
| Jun 30, 2022 | -627,000.00 |
| Mar 31, 2022 | -185,000.00 |
| Dec 31, 2021 | -567,000.00 |
| Sep 30, 2021 | -416,000.00 |
| Jun 30, 2021 | -387,000.00 |
| Mar 31, 2021 | -255,000.00 |
| Dec 31, 2020 | -230,000.00 |